标准和延长的甲持续时间对严重COVID-19患者的死亡率的比较
Andrew Sephien1, Marc Lozano2, Sean-Patrick Prince2
1From the Division of Cardiovascular Disease, University of Miami/Jackson Memorial Hospital, Miami, FL.
Southern medical journal
|December 2, 2024
概括
与标准的10天疗程相比,在重症COVID-19患者中长期使用德克萨米他会增加住院死亡率. 这一发现表明,较短的德克萨米他持续时间可能对危急的冠状病毒疾病2019患者更安全.
科学领域:
- 临界护理医学 临界护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的指导方针建议德克萨米他用于严重的COVID-19.
- 德克萨米他的使用情况各不相同,常见的是长时间 (>10天) 的使用.
- 标准德甲与扩展德甲的好处和风险需要评估.
研究的目的:
- 为了比较标准 (≤10天) 与延长 (>10天) 德甲使用的风险和益处.
- 为了评估严重的COVID-19患者在医院死亡率的影响.
主要方法:
- 多中心回顾性队列研究 (2021年1月至2021年12月).
- 包括接受6毫克/天德克萨米他的严重COVID-19患者.
- 主要结局:住院死亡率.
主要成果:
- 分析了1294名患者 (803名标准,491名扩展).
- 扩展组 (36.5%) 与标准组 (28.5%) (P=0.003) 的住院死亡率较高.
- 在主要心脏不良事件中没有显著差异.
结论:
- 长期使用德克萨米他与严重COVID-19的住院死亡率增加有关.
- 研究结果表明,标准持续时间可能更安全.
- 需要随机对照试验来确认.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
150
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
150
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K


